Skip to content
lifestyle.easyhouseremodeling.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Telix Pharmaceuticals Limited
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
April 7, 2026
Telix Appoints David Gill as Non-Executive Director
April 1, 2026
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
March 15, 2026
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
March 12, 2026
Investor Education Webinar
March 11, 2026
Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging
March 11, 2026
Telix to Participate in Oppenheimer and TD Cowen Conferences
March 10, 2026
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
March 10, 2026
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
March 9, 2026
Telix Full Year Results 2025 Investor Webcast Notification
February 3, 2026
←
Previous Page
1
2
3
Next Page
→